The 26RFa (QRFP)/GPR103 neuropeptidergic system: A key regulator of energy and glucose metabolism
M Devère, S Takhlidjt, G Prévost, N Chartrel… - …, 2024 - karger.com
Background: Obesity and type 2 diabetes are strongly associated pathologies, currently
considered as a worldwide epidemic problem. Understanding the mechanisms that drive the …
considered as a worldwide epidemic problem. Understanding the mechanisms that drive the …
[HTML][HTML] Why Search for Alternative GPCR Agonists?
JA Boutin, J Leprince - Receptors, 2023 - mdpi.com
Intuitively, it is easy to understand why we search for G protein-coupled receptor (GPCR)
antagonists. It is obviously to block a functionality of a specific receptor potentially linked to …
antagonists. It is obviously to block a functionality of a specific receptor potentially linked to …
The 26RFa (QRFP)/GPR103 Neuropeptidergic System: A Key Regulator of Energy and Glucose Metabolism
MDSTG Prévosta, N Chartrela, J Leprincea, M Picota - 2024 - karger.com
Background: Obesity and type 2 diabetes are strongly associated pathologies, currently
considered as a worldwide epidemic problem. Understanding the mechanisms that drive the …
considered as a worldwide epidemic problem. Understanding the mechanisms that drive the …
Platelet-activating factor receptor in GtoPdb v. 2023.1
R Hills, S Ishii, S Jancar, T McIntyre… - IUPHAR/BPS Guide …, 2023 - journals.ed.ac.uk
Abstract Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is
an ether phospholipid mediator associated with platelet coagulation, but also subserves …
an ether phospholipid mediator associated with platelet coagulation, but also subserves …